Abstract
We previously demonstrated that Bothrops jararaca venom (BjV) has an antitumor effect on Ehrlich ascites tumor (EAT) cells and induces an increase of polymorphonuclear leukocytes in early stages of tumor growth. It has been reported that this venom presents an important inflammatory effect when inoculated in animal models and in human snakebites, and that cytokine levels have been detected in these cases. To evaluate whether the cytokines can be involved with the suppression of the tumoral growth, we evaluate the cytokine profile in the peritoneal cavity of mice inoculated with EAT cells and treated with BjV. Swiss mice were inoculated with EAT cells by the intraperitoneal route and treated with BjV venom (0.4 mg/kg, intraperitoneally), on the 1st, 4th, 7th, 10th, and 13th day. Mice were evaluated for cytokine levels on the 2nd, 5th, 8th, 11th and 14th day. Analysis was performed using an enzyme-linked immunosorbent assay for interleukin (IL)-1alpha, IL-2, IL4, IL-6, IL-10, IL-13, and tumor necrosis factor-alpha (TNF-alpha) levels in the peritoneal washing supernatant. Results were analyzed statistically by the Kruskal-Wallis and Dunn's tests at the 5% level of significance. We observed that EAT implantation induces IL-6 production on the 11th and 14th days of tumor growth, IL-10 on the 11th day and TNF-alpha on the 14th day. The treatment with BjV suppresses production of these cytokines. In addition, IL-13 was produced by animals that were inoculated only with venom on the 11th and 14th days, and by the group inoculated with EAT cells and treated with venom on the 2nd and 14th days. Furthermore, we suggest that the IL-6 detected in the present study is produced by the EAT cells and the suppression of its production could be associated with the antitumor effect of BjV.
Full Text
The Full Text of this article is available as a PDF (294.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahn M. Y., Lee B. M., Kim Y. S. Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah). Int J Biochem Cell Biol. 1997 Jun;29(6):911–919. doi: 10.1016/s1357-2725(97)00024-1. [DOI] [PubMed] [Google Scholar]
- Beissert S., Bergholz M., Waase I., Lepsien G., Schauer A., Pfizenmaier K., Krönke M. Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5064–5068. doi: 10.1073/pnas.86.13.5064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brunda M. J., Luistro L., Warrier R. R., Wright R. B., Hubbard B. R., Murphy M., Wolf S. F., Gately M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med. 1993 Oct 1;178(4):1223–1230. doi: 10.1084/jem.178.4.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cardoso D. F., Mota I. Effect of Crotalus venom on the humoral and cellular immune response. Toxicon. 1997 Apr;35(4):607–612. doi: 10.1016/s0041-0101(96)00134-1. [DOI] [PubMed] [Google Scholar]
- Elexpuru A., Martín-Nieto J., Jimenez A., Gómez C., Villalobo A. Ehrlich ascites tumor cells produce a transforming growth factor-beta (TGFbeta)-like activity but lack receptors with TGFbeta-binding capacity. Mol Cell Biochem. 1997 May;170(1-2):153–162. doi: 10.1023/a:1006809604193. [DOI] [PubMed] [Google Scholar]
- Halak B. K., Maguire H. C., Jr, Lattime E. C. Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site. Cancer Res. 1999 Feb 15;59(4):911–917. [PubMed] [Google Scholar]
- Kimura H., Yamashita S., Namba H., Tominaga T., Tsuruta M., Yokoyama N., Izumi M., Nagataki S. Interleukin-1 inhibits human thyroid carcinoma cell growth. J Clin Endocrinol Metab. 1992 Aug;75(2):596–602. doi: 10.1210/jcem.75.2.1322431. [DOI] [PubMed] [Google Scholar]
- Kinoshita T., Ito H., Miki C. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma. Cancer. 1999 Jun 15;85(12):2526–2531. doi: 10.1002/(sici)1097-0142(19990615)85:12<2526::aid-cncr6>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- Kuo W. N., Ganesan U., Robinson A., Flanders J. R., Fausti M. E., Jean M. N., Gurnee M. L., Kuo J. Proteolysis of interleukin-2, interferon and immunoglobulin by venoms. Cytobios. 1991;67(270-271):145–151. [PubMed] [Google Scholar]
- Lomonte B., Tarkowski A., Hanson L. A. Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation. 1993 Apr;17(2):93–105. doi: 10.1007/BF00916097. [DOI] [PubMed] [Google Scholar]
- Obiri N. I., Husain S. R., Debinski W., Puri R. K. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain. Clin Cancer Res. 1996 Oct;2(10):1743–1749. [PubMed] [Google Scholar]
- Onozaki K., Matsushima K., Aggarwal B. B., Oppenheim J. J. Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol. 1985 Dec;135(6):3962–3968. [PubMed] [Google Scholar]
- Pessatti M., Fontana J. D., Furtado M. F., Guimãraes M. F., Zanette L. R., Costa W. T., Baron M. Screening of Bothrops snake venoms for L-amino acid oxidase activity. Appl Biochem Biotechnol. 1995 Spring;51-52:197–210. doi: 10.1007/BF02933424. [DOI] [PubMed] [Google Scholar]
- Petricevich V. L., Teixeira C. F., Tambourgi D. V., Gutiérrez J. M. Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms. Toxicon. 2000 Sep;38(9):1253–1266. doi: 10.1016/s0041-0101(99)00227-5. [DOI] [PubMed] [Google Scholar]
- Raibekas A. A., Massey V. Primary structure of the snake venom L-amino acid oxidase shows high homology with the mouse B cell interleukin 4-induced Fig1 protein. Biochem Biophys Res Commun. 1998 Jul 30;248(3):476–478. doi: 10.1006/bbrc.1998.9024. [DOI] [PubMed] [Google Scholar]
- Serve H., Oelmann E., Herweg A., Oberberg D., Serve S., Reufi B., Mücke C., Minty A., Thiel E., Berdel W. E. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Cancer Res. 1996 Aug 1;56(15):3583–3588. [PubMed] [Google Scholar]
- Spriggs D., Imamura K., Rodriguez C., Horiguchi J., Kufe D. W. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6563–6566. doi: 10.1073/pnas.84.18.6563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tan N. H., Ponnudurai G. A comparative study of the biological properties of some venoms of snakes of the genus Bothrops (American lance-headed viper). Comp Biochem Physiol B. 1991;100(2):361–365. doi: 10.1016/0305-0491(91)90387-s. [DOI] [PubMed] [Google Scholar]
- Toi M., Bicknell R., Harris A. L. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res. 1992 Jan 15;52(2):275–279. [PubMed] [Google Scholar]
- Wagstaff J., Baars J. W., Wolbink G. J., Hoekman K., Eerenberg-Belmer A. J., Hack C. E. Renal cell carcinoma and interleukin-2: a review. Eur J Cancer. 1995;31A(3):401–408. doi: 10.1016/0959-8049(94)00494-p. [DOI] [PubMed] [Google Scholar]
- Walos S., Szary J., Szala S. Inhibition of tumor growth by interleukin 10 gene transfer in B16(F10) melanoma cells. Acta Biochim Pol. 1999;46(4):967–970. [PubMed] [Google Scholar]
- Watson J. M., Sensintaffar J. L., Berek J. S., Martínez-Maza O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res. 1990 Nov 1;50(21):6959–6965. [PubMed] [Google Scholar]
- da Silva Reinaldo J., da Silva Márcia G., Vilela Lízia C., Fecchio Denise. Antitumor effect of Bothrops jararaca venom. Mediators Inflamm. 2002 Apr;11(2):99–104. doi: 10.1080/09629350220131953. [DOI] [PMC free article] [PubMed] [Google Scholar]